227 related articles for article (PubMed ID: 21682961)
1. Countrywide management of pulmonary tuberculosis reverses increasing incidence.
Blöndal K; Viiklepp P; Blöndal P; Altraja A
Int J Tuberc Lung Dis; 2011 Jul; 15(7):892-8. PubMed ID: 21682961
[TBL] [Abstract][Full Text] [Related]
2. High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia.
Jugheli L; Rigouts L; Shamputa IC; Bram de Rijk W; Portaels F
Int J Tuberc Lung Dis; 2008 May; 12(5):561-6. PubMed ID: 18419893
[TBL] [Abstract][Full Text] [Related]
3. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
Kliiman K; Altraja A
Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
[TBL] [Abstract][Full Text] [Related]
5. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
Palacios E; Franke M; Muñoz M; Hurtado R; Dallman R; Chalco K; Guerra D; Mestanza L; Llaro K; Bonilla C; Sebastian J; Bayona J; Lygizos M; Anger H; Shin S
Int J Tuberc Lung Dis; 2012; 16(3):348-54. PubMed ID: 22640448
[TBL] [Abstract][Full Text] [Related]
6. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
Reechaipichitkul W
Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
[TBL] [Abstract][Full Text] [Related]
7. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
[TBL] [Abstract][Full Text] [Related]
8. Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics?
Dubrovina I; Miskinis K; Lyepshina S; Yann Y; Hoffmann H; Zaleskis R; Nunn P; Zignol M
Int J Tuberc Lung Dis; 2008 Jul; 12(7):756-62. PubMed ID: 18544200
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of tuberculosis in Ottawa, Canada, 1995-2004.
Kim J; Langevin M; Wylie EL; McCarthy AE
Int J Tuberc Lung Dis; 2008 Oct; 12(10):1128-33. PubMed ID: 18812041
[TBL] [Abstract][Full Text] [Related]
10. An outbreak of multidrug-resistant tuberculosis among refugees in Austria, 2005-2006.
Schmid D; Fretz R; Kuo HW; Rumetshofer R; Meusburger S; Magnet E; Hürbe G; Indra A; Ruppitsch W; Pietzka AT; Allerberger F
Int J Tuberc Lung Dis; 2008 Oct; 12(10):1190-5. PubMed ID: 18812050
[TBL] [Abstract][Full Text] [Related]
11. Pilot study on multidrug resistant tuberculosis in Nigeria.
Lawson L; Habib AG; Okobi MI; Idiong D; Olajide I; Emenyonu N; Onuoha N; Cuevas LE; Ogiri SO
Ann Afr Med; 2010; 9(3):184-7. PubMed ID: 20710112
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.
Schreiber YS; Herrera AF; Wilson D; Wallengren K; Draper R; Muller J; Dawood H; Doucette S; Cameron DW; Alvarez GG
Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433
[TBL] [Abstract][Full Text] [Related]
13. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
14. Drug-resistant tuberculosis in South African gold miners: incidence and associated factors.
Churchyard GJ; Corbett EL; Kleinschmidt I; Mulder D; De Cock KM
Int J Tuberc Lung Dis; 2000 May; 4(5):433-40. PubMed ID: 10815737
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis in Europe: a problem of drug resistance or much more?
Carvalho AC; Migliori GB; Cirillo DM
Expert Rev Respir Med; 2010 Apr; 4(2):189-200. PubMed ID: 20406085
[TBL] [Abstract][Full Text] [Related]
16. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
Kenyon TA; Mwasekaga MJ; Huebner R; Rumisha D; Binkin N; Maganu E
Int J Tuberc Lung Dis; 1999 Jan; 3(1):4-11. PubMed ID: 10094163
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis and management of HIV/TB co-infection in Asia.
Goldfeld A; Ellner JJ
Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S26-30. PubMed ID: 17606407
[TBL] [Abstract][Full Text] [Related]
18. [Impact of anti-tuberculosis drug resistance on treatment outcome of pulmonary tuberculosis patients receiving directly observed treatment strategy in Henan Province, China].
Wang GJ; Xu JY; Wang GB; Zhen XA; Gao SY; Du CM
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):527-30. PubMed ID: 17074265
[TBL] [Abstract][Full Text] [Related]
19. Trends in childhood tuberculosis in Zambia: a situation analysis.
Kapata N; Chanda-Kapata P; O'Grady J; Bates M; Mwaba P; Janssen S; Marais B; Cobelens F; Grobusch M; Zumla A
J Trop Pediatr; 2013 Apr; 59(2):134-9. PubMed ID: 23243079
[TBL] [Abstract][Full Text] [Related]
20. Drug-resistant tuberculosis in human immunodeficiency virus infected persons in Italy. The Italian Drug-Resistant Tuberculosis Study Group.
Angarano G; Carbonara S; Costa D; Gori A
Int J Tuberc Lung Dis; 1998 Apr; 2(4):303-11. PubMed ID: 9559401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]